The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease

Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials

(2021) Kah Kheng Goh et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses

(2021) Armida Mucci et al.   JAMA Psychiatry

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

(2020) Robert  A. McCutcheon et al.   World Psychiatry

A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology

(2020) Daniel C. Javitt et al.   NEUROPSYCHOPHARMACOLOGY

Autoimmunity and NMDA receptor in brain disorders: Where do we stand?

(2020) Daniel Hunter et al.   NEUROBIOLOGY OF DISEASE

Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia

(2019) Alice Medalia et al.   SCHIZOPHRENIA RESEARCH

Differential patterns of visual sensory alteration underlying face emotion recognition impairment and motion perception deficits in schizophrenia and autism spectrum disorders

(2019) Antígona Martínez et al.   BIOLOGICAL PSYCHIATRY

Targeted Treatment of Individuals with Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene

(2019) J. Alexander Bodkin et al.   BIOLOGICAL PSYCHIATRY

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

(2019) Josep Dalmau et al.   LANCET NEUROLOGY

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis

(2019) Stefan Leucht et al.   NEUROPSYCHOPHARMACOLOGY

Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia

(2019) Clément Dondé et al.   Translational Psychiatry

The thalamocortical circuit of auditory mismatch negativity

(2019) Peter Lakatos et al.   BIOLOGICAL PSYCHIATRY

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders

(2018) Daniel C. Javitt et al.   JAMA Psychiatry

Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications

(2018) Antígona Martínez et al.   AMERICAN JOURNAL OF PSYCHIATRY

Neural mechanisms of mismatch negativity dysfunction in schizophrenia

(2017) M Lee et al.   MOLECULAR PSYCHIATRY

Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia

(2017) Migyung Lee et al.   NEUROPSYCHOPHARMACOLOGY

Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia

(2017) Michael L. Thomas et al.   JAMA Psychiatry

A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia

(2017) Migyung Lee et al.   SCHIZOPHRENIA RESEARCH

Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms

(2017) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia

(2017) Daniel C. Javitt et al.   SCHIZOPHRENIA RESEARCH

Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia

(2017) Michael Avissar et al.   SCHIZOPHRENIA RESEARCH

Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine

(2016) Joshua T. Kantrowitz et al.   BRAIN

New statistical approaches exploit the polygenic architecture of schizophrenia—implications for the underlying neurobiology

(2016) Andrew J Schork et al.   CURRENT OPINION IN NEUROBIOLOGY

Genome-wide association study of schizophrenia in Ashkenazi Jews

(2015) Fernando S. Goes et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia

(2015) Daniel C. Javitt et al.   AMERICAN JOURNAL OF PSYCHIATRY

Altered Glutamate Protein Co-Expression Network Topology Linked to Spine Loss in the Auditory Cortex of Schizophrenia

(2015) Matthew L. MacDonald et al.   BIOLOGICAL PSYCHIATRY

Auditory dysfunction in schizophrenia: integrating clinical and basic features

(2015) Daniel C. Javitt et al.   NATURE REVIEWS NEUROSCIENCE

The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies

(2014) Wei Hu et al.   Annals of the New York Academy of Sciences

Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings

(2014) Eline M.P. Poels et al.   SCHIZOPHRENIA RESEARCH

Placebo Response in Antipsychotic Clinical Trials

(2014) Bret R. Rutherford et al.   JAMA Psychiatry

Nonhuman primate model of schizophrenia using a noninvasive EEG method

(2013) R. Gil-da-Costa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differential Relationships of Mismatch Negativity and Visual P1 Deficits to Premorbid Characteristics and Functional Outcome in Schizophrenia

(2011) Tamara Friedman et al.   BIOLOGICAL PSYCHIATRY

When Doors of Perception Close: Bottom-up Models of Disrupted Cognition in Schizophrenia

(2009) Daniel C. Javitt   Annual Review of Clinical Psychology

Magnocellular Pathway Impairment in Schizophrenia: Evidence from Functional Magnetic Resonance Imaging

(2008) A. Martinez et al.   JOURNAL OF NEUROSCIENCE

N-methyl-d-aspartic acid receptor antagonist–induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia

(2008) R.S. Ehrlichman et al.   NEUROSCIENCE